|
Sr. Director, Global Commercial Strategy Oncology, Portfolio Strategy & Early Development - Raritan New Jersey
Company: Disability Solutions Location: Raritan, New Jersey
Posted On: 05/03/2024
Johnson & Johnson, is recruiting for a Sr. Director, Portfolio Strategy & Early Development in our Global Commercial Strategy Organization. The position is based in Raritan, New Jersey At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at . We are Johnson & Johnson. Our mission drives us. Our patients inspire us. We collaborate with the world for the health of everyone in it. We are guided by our . Thriving on a diverse company culture, celebrating the uniqueness of our employees and committed to inclusion. Proud to be an equal opportunity employer. The Sr. Director, Global Commercial Strategy Oncology, ST3 DAS, Portfolio Strategy & Early Development reports to the Vice President, Commercial Disease Area Strategy (DAS) Leader for ST3 (Solid Tumors Targeted Therapy) and leads a team of Global Strategic Marketing Manager(s). The Sr Director is responsible for leading the portfolio strategy for our ST3 DAS, including amivantamab. The Sr. Director, Global Commercial Strategy Oncology, ST3 DAS, Portfolio Strategy & Early Development contributes to optimizing the value of our global portfolio in collaboration with key functions across the Global Commercial Strategy Organization (GCSO), Research and Development (R&D), and business regions. Key Responsibilities: |
|